Search Results - Teji Singh
- Showing 1 - 3 results of 3
-
1
-
2
Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscu... by Jerry R. Mendell, Perry B. Shieh, Craig M. McDonald, Zarife Sahenk, Kelly J. Lehman, Linda Lowes, Natalie F. Reash, M. Iammarino, Lindsay N. Alfano, Brenna Sabo, Jeremy D. Woods, Christy Skura, Howard C. Mao, Loretta A. Staudt, Danielle A. Griffin, Sarah J. Lewis, Shufang Wang, Rachael A. Potter, Teji Singh, Louise R. Rodino‐Klapac
Published 2023Artigo -
3
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial by Jerry R. Mendell, Francesco Muntoni, Craig M. McDonald, Eugenio Mercuri, Emma Ciafaloni, Hirofumi Komaki, Carmen Leon‐Astudillo, A. Nascimento, Crystal M. Proud, Ulrike Schara‐Schmidt, Aravindhan Veerapandiyan, Craig M. Zaidman, Maitea Guridi, Alexander P. Murphy, Carol Reid, Christoph Wandel, Damon R. Asher, Eddie Darton, Stefanie Mason, Rachael A. Potter, Teji Singh, Wenfei Zhang, Paulo Fontoura, Jacob Elkins, Louise R. Rodino‐Klapac
Published 2024Artigo